Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

M. M. Smits; L. Tonneijck; M. H. A. Muskiet; M. H. H. Kramer; M. Diamant; I. C. Pieters-van den Bos; D. H. van Raalte; D. L. Cahen

doi:https://doi.org/10.1111/dom.12612

Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

M. M. Smits, L. Tonneijck, M. H. A. Muskiet, M. H. H. Kramer, M. Diamant, I. C. Pieters-van den Bos, D. H. van Raalte, D. L. Cahen

Internal Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	281-288
Journal	Diabetes, Obesity and Metabolism
Volume	18
Issue number	3
DOIs	https://doi.org/10.1111/dom.12612
Publication status	Published - Mar 2016

Keywords

exenatide
exocrine pancreatic function
glucagon-like peptide-1 receptor agonists
pancreatitis
type 2 diabetes

Access to Document

https://doi.org/10.1111/dom.12612

Cite this

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Diamant, M., Pieters-van den Bos, I. C., van Raalte, D. H., & Cahen, D. L. (2016). Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial. Diabetes, Obesity and Metabolism, 18(3), 281-288. https://doi.org/10.1111/dom.12612

@article{ea6889780d164b49a7bfc4403b021416,

title = "Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial",

keywords = "exenatide, exocrine pancreatic function, glucagon-like peptide-1 receptor agonists, pancreatitis, type 2 diabetes",

author = "Smits, {M. M.} and L. Tonneijck and Muskiet, {M. H. A.} and Kramer, {M. H. H.} and M. Diamant and {Pieters-van den Bos}, {I. C.} and {van Raalte}, {D. H.} and Cahen, {D. L.}",

year = "2016",

month = mar,

doi = "https://doi.org/10.1111/dom.12612",

language = "English",

volume = "18",

pages = "281--288",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "3",

}

Smits, MM , Tonneijck, L , Muskiet, MHA , Kramer, MHH, Diamant, M, Pieters-van den Bos, IC, van Raalte, DH & Cahen, DL 2016, 'Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial', Diabetes, Obesity and Metabolism, vol. 18, no. 3, pp. 281-288. https://doi.org/10.1111/dom.12612

Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial. / Smits, M. M.; Tonneijck, L.; Muskiet, M. H. A. et al.
In: Diabetes, Obesity and Metabolism, Vol. 18, No. 3, 03.2016, p. 281-288.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

AU - Smits, M. M.

AU - Tonneijck, L.

AU - Muskiet, M. H. A.

AU - Kramer, M. H. H.

AU - Diamant, M.

AU - Pieters-van den Bos, I. C.

AU - van Raalte, D. H.

AU - Cahen, D. L.

PY - 2016/3

Y1 - 2016/3

KW - exenatide

KW - exocrine pancreatic function

KW - glucagon-like peptide-1 receptor agonists

KW - pancreatitis

KW - type 2 diabetes

U2 - https://doi.org/10.1111/dom.12612

DO - https://doi.org/10.1111/dom.12612

M3 - Article

C2 - 26640129

SN - 1462-8902

VL - 18

SP - 281

EP - 288

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 3

ER -